Crossmark

Safety of Semaglutide

Crossref DOI link: https://doi.org/10.3389/fendo.2021.645563

Published Online: 2021-07-07

Update policy: https://doi.org/10.3389/crossmark-policy

Authors

Smits, Mark M.

Van Raalte, Daniël H.
Funding

Funding for this research was provided by:

Novo Nordisk
License Information

Version of Record valid from 2021-07-07